Deltec Asset Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$53K | – | 321 |
|
|
2021
Q2 | $53K | Hold |
10,000
| – | – | 0.01% | 291 |
|
|
2021
Q1 | $48K | Sell |
10,000
-235,399
| -96% | -$1.13M | 0.01% | 289 |
|
|
2020
Q4 | $1.06M | Sell |
245,399
-110,446
| -31% | -$478K | 0.16% | 102 |
|
|
2020
Q3 | $1.47M | Hold |
355,845
| – | – | 0.26% | 79 |
|
|
2020
Q2 | $911K | Sell |
355,845
-46,000
| -11% | -$118K | 0.19% | 116 |
|
|
2020
Q1 | $1.16M | Buy |
401,845
+3,236
| +0.8% | +$9.35K | 0.32% | 56 |
|
|
2019
Q4 | $1.51M | Sell |
398,609
-176,277
| -31% | -$668K | 0.31% | 60 |
|
|
2019
Q3 | $2.94M | Buy |
574,886
+24,050
| +4% | +$123K | 0.74% | 40 |
|
|
2019
Q2 | $3.42M | Buy |
550,836
+14,000
| +3% | +$86.8K | 0.75% | 36 |
|
|
2019
Q1 | $3.82M | Buy |
536,836
+300,712
| +127% | +$2.14M | 0.83% | 31 |
|
|
2018
Q4 | $2.02M | Sell |
236,124
-143,300
| -38% | -$1.22M | 0.56% | 45 |
|
|
2018
Q3 | $7.6M | Buy |
379,424
+19,628
| +5% | +$393K | 1.46% | 20 |
|
|
2018
Q2 | $9.29M | Buy |
359,796
+139,500
| +63% | +$3.6M | 1.88% | 15 |
|
|
2018
Q1 | $5.27M | Buy |
220,296
+119,996
| +120% | +$2.87M | 1.05% | 30 |
|
|
2017
Q4 | $3.4M | Buy |
+100,300
| New | +$3.4M | 0.69% | 47 |
|